Potential role of NADPH oxidase-mediated activation of Jak2/Stat3 and mitogen-activated protein kinases and expression of TGF-β1 in the pathophysiology of acute pancreatitis

Inflamm Res. 2011 Aug;60(8):791-800. doi: 10.1007/s00011-011-0335-4. Epub 2011 Apr 21.

Abstract

Objective: NADPH oxidase is potentially associated with acute pancreatitis by producing reactive oxygen species (ROS). We investigated whether NADPH oxidase mediates the activation of Janus kinase (Jak)2/signal transducers and activators of transcription (Stat)3 and mitogen-activated protein kinases (MAPKs) to induce the expression of transforming growth factor-β1 (TGF-β1) in cerulein-stimulated pancreatic acinar cells.

Treatment: AR42J cells were treated with an NADPH oxidase inhibitor diphenyleneiodonium (DPI) or a Jak2 inhibitor AG490. Other cells were transfected with antisense or sense oligonucleotides (AS or S ODNs) for NADPH oxidase subunit p22(phox) or p47(phox).

Methods: TGF-β1 was determined by enzyme-linked immonosorbent assay. STAT3-DNA binding activity was measured by electrophoretic mobility shift assay. Levels of MAPKs as well as total and phospho-specific forms of Jak1/Stat3 were assessed by Western blot analysis.

Results: Cerulein induced increases in TGF-β1, Stat3-DNA binding activity and the activation of MAPKs in AR42J cells. AG490 suppressed these cerulein-induced changes, similar to inhibition by DPI. Cerulein-induced activation of Jak2/Stat3 and increases in MAPKs and TGF-β1 levels were inhibited in the cells transfected with AS ODN for p22(phox) and p47(phox) compared to S ODN controls.

Conclusion: Inhibition of NADPH oxidase may be beneficial for prevention and treatment of pancreatitis by suppressing Jak2/Stat3 and MAPKs and expression of TGF-β1 in pancreatic acinar cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line
  • Ceruletide / pharmacology
  • Enzyme Activation*
  • Enzyme Inhibitors / metabolism
  • Humans
  • Janus Kinase 2 / metabolism*
  • Mitogen-Activated Protein Kinases / metabolism*
  • NADPH Oxidases / genetics
  • NADPH Oxidases / metabolism*
  • Pancreas, Exocrine / cytology
  • Pancreas, Exocrine / drug effects
  • Pancreas, Exocrine / metabolism
  • Pancreatitis / physiopathology*
  • Rats
  • Reactive Oxygen Species / metabolism
  • STAT3 Transcription Factor / metabolism*
  • Transforming Growth Factor beta1 / metabolism*
  • Tyrphostins / metabolism

Substances

  • Enzyme Inhibitors
  • Reactive Oxygen Species
  • STAT3 Transcription Factor
  • Transforming Growth Factor beta1
  • Tyrphostins
  • alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide
  • Ceruletide
  • NADPH Oxidases
  • Janus Kinase 2
  • Mitogen-Activated Protein Kinases